These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24066076)

  • 1. Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010.
    Panozzo CA; Becker-Dreps S; Pate V; Jonsson Funk M; Stürmer T; Weber DJ; Brookhart MA
    PLoS One; 2013; 8(9):e73825. PubMed ID: 24066076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites.
    Pringle K; Cardemil CV; Pabst LJ; Parashar UD; Cortese MM
    Vaccine; 2016 Dec; 34(50):6396-6401. PubMed ID: 27810316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Incidence Rate of Type 1 Diabetes after Receipt of the Rotavirus Vaccine in the United States, 2001-2017.
    Rogers MAM; Basu T; Kim C
    Sci Rep; 2019 Jun; 9(1):7727. PubMed ID: 31197227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    Wilson SE; Chung H; Schwartz KL; Guttmann A; Deeks SL; Kwong JC; Crowcroft NS; Wing L; Tu K
    PLoS One; 2018; 13(2):e0192809. PubMed ID: 29444167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Fathima P; Gidding HF; Snelling TL; McIntyre PB; Blyth CC; Sheridan S; Liu B; de Klerk N; Moore HC
    Vaccine; 2019 Sep; 37(39):5835-5843. PubMed ID: 31443995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
    Desai S; Rathi N; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay NJ; Venugopal P; Palkar S; Munshi R; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Uttam KG; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Deshpande J; Nalavade U; Sharma D; Bansal A; Tang Y; Flores J; Kulkarni PS
    Vaccine; 2018 Sep; 36(37):5519-5523. PubMed ID: 30104114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
    Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance.
    Calnan M; Krishnarajah G; Duh MS; Haider BA; Yermakov S; Davis M; Yan S
    Hum Vaccin Immunother; 2016 May; 12(5):1235-43. PubMed ID: 26900728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
    Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
    Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.
    Cortese MM; Tate JE; Simonsen L; Edelman L; Parashar UD
    Pediatr Infect Dis J; 2010 Jun; 29(6):489-94. PubMed ID: 20354464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):521-4. PubMed ID: 20448529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use.
    Daskalaki I; Spain CV; Long SS; Watson B
    Pediatrics; 2008 Jul; 122(1):e33-8. PubMed ID: 18595974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.